Multiple Assemblies exist for SMTL entry 4fw5
Crystal Structure of the LpxC in complex with 4'-BROMO-N-[(2S,3R)-3-HYDROXY-1-(HYDROXYAMINO)-1-OXOBUTAN-2-YL]BIPHENYL-4-CARBOXAMIDE inhibitor; X-RAY DIFFRACTION 1.99 Å

	SMTL ID 4fw5.1 Ligands ZINC ION; 4'-bromo-N-[(2S,3R)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]biphenyl-4-carboxamide; ACETATE ION; GLYCEROL Polypeptides UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase Oligo-state monomer
	SMTL ID 4fw5.2 Ligands ZINC ION; 4'-bromo-N-[(2S,3R)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]biphenyl-4-carboxamide; ACETATE ION; GLYCEROL Polypeptides UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase Oligo-state monomer
	SMTL ID 4fw5.3 Ligands ZINC ION; 4'-bromo-N-[(2S,3R)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]biphenyl-4-carboxamide; ACETATE ION; GLYCEROL Polypeptides UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase Oligo-state monomer
	SMTL ID 4fw5.4 Ligands ZINC ION; 4'-bromo-N-[(2S,3R)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]biphenyl-4-carboxamide; GLYCEROL Polypeptides UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase Oligo-state monomer